Basit öğe kaydını göster

dc.contributor.authorAyhan, Ali
dc.contributor.authorAkilli, Huseyin
dc.date.accessioned2021-04-19T08:06:24Z
dc.date.available2021-04-19T08:06:24Z
dc.date.issued2020
dc.identifier.issn2045-7634en_US
dc.identifier.urihttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/cam4.3605
dc.identifier.urihttp://hdl.handle.net/11727/5702
dc.description.abstractBackground The impact of the COVID-19 pandemic on European gynaecological cancer patients under active treatment or follow-up has not been documented. We sought to capture the patient perceptions of the COVID-19 implications and the worldwide imposed treatment modifications. Methods A patient survey was conducted in 16 European countries, using a new COVID-19-related questionnaire, developed by ENGAGe and the Hospital Anxiety & Depression Scale questionnaire (HADS). The survey was promoted by national patient advocacy groups and charitable organisations. Findings We collected 1388 forms; 592 online and 796 hard-copy (May, 2020). We excluded 137 due to missing data. Median patients' age was 55 years (range: 18-89), 54.7% had ovarian cancer and 15.5% were preoperative. Even though 73.2% of patients named cancer as a risk factor for COVID-19, only 17.5% were more afraid of COVID-19 than their cancer condition, with advanced age (>70 years) as the only significant risk factor for that. Overall, 71% were concerned about cancer progression if their treatment/follow-up was cancelled/postponed. Most patients (64%) had their care continued as planned, but 72.3% (n = 892) said that they received no information around overall COVID-19 infection rates of patients and staff, testing or measures taken in their treating hospital. Mean HADS Anxiety and Depression Scores were 8.8 (range: 5.3-12) and 8.1 (range: 3.8-13.4), respectively. Multivariate analysis identified high HADS-depression scores, having experienced modifications of care due to the pandemic and concern about not being able to visit their doctor as independent predictors of patients' anxiety. Interpretation Gynaecological cancer patients expressed significant anxiety about progression of their disease due to modifications of care related to the COVID-19 pandemic and wished to pursue their treatment as planned despite the associated risks. Healthcare professionals should take this into consideration when making decisions that impact patients care in times of crisis and to develop initiatives to improve patients' communication and education.en_US
dc.language.isoengen_US
dc.relation.isversionof10.1002/cam4.3605en_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectanxietyen_US
dc.subjectcanceren_US
dc.subjectCOVID&#8208en_US
dc.subject19en_US
dc.subjectdepressionen_US
dc.subjectEUen_US
dc.subjectexpectationen_US
dc.subjectgynaecologic oncologyen_US
dc.subjectpatientsen_US
dc.subjectperspectivesen_US
dc.titlePerspectives, fears and expectations of patients with gynaecological cancers during the COVID-19 pandemic: A Pan-European study of the European Network of Gynaecological Cancer Advocacy Groups (ENGAGe)en_US
dc.typearticleen_US
dc.relation.journalCANCER MEDICINEen_US
dc.identifier.volume10en_US
dc.identifier.issue1en_US
dc.identifier.startpage208en_US
dc.identifier.endpage219en_US
dc.identifier.wos000590785200001en_US
dc.identifier.scopus2-s2.0-85096674613en_US
dc.contributor.pubmedID33205595en_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergien_US
dc.contributor.researcherIDAAJ-5802-2021en_US
dc.contributor.researcherIDAAX-3230-2020en_US


Bu öğenin dosyaları:

Thumbnail

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster